Safety, Tolerability, and Pharmacokinetics of HSK21542 in Healthy Volunteers

NCT04110886 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain
Chronic Pain

Interventions

DRUG: HSK21542
DRUG: Placebo

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd